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Abstract
Background: Little is known about the neurocognitive outcome in children exposed to perinatal mother-to-child
Chikungunya virus (p-CHIKV) infection.
Methods: The CHIMERE ambispective cohort study compared the neurocognitive function of 33 p-CHIKV-infected children (all
but one enrolled retrospectively) at around two years of age with 135 uninfected peers (all enrolled prospectively). Psychomotor
development was assessed using the revised Brunet-Lezine scale, examiners blinded to infectious status. Development
quotients (DQ) with subscores covering movement/posture, coordination, language, sociability skills were calculated. Predictors
of global neurodevelopmental delay (GND, DQ#85), were investigated using multivariate Poisson regression modeling.
Neuroradiologic follow-up using magnetic resonance imaging (MRI) scans was proposed for most of the children with severe
forms.
Results: The mean DQ score was 86.3 (95%CI: 81.0–91.5) in infected children compared to 100.2 (95%CI: 98.0–102.5) in
uninfected peers (P,0.001). Fifty-one percent (n = 17) of infected children had a GND compared to 15% (n = 21) of
uninfected children (P,0.001). Specific neurocognitive delays in p-CHIKV-infected children were as follows: coordination
and language (57%), sociability (36%), movement/posture (27%). After adjustment for maternal social situation, small for
gestational age, and head circumference, p-CHIKV infection was found associated with GND (incidence rate ratio: 2.79,
95%CI: 1.45–5.34). Further adjustments on gestational age or breastfeeding did not change the independent effect of CHIKV
infection on neurocognitive outcome. The mean DQ of p-CHIKV-infected children was lower in severe encephalopathic
children than in non-severe children (77.6 versus 91.2, P,0.001). Of the 12 cases of CHIKV neonatal encephalopathy, five
developed a microcephaly (head circumference ,22 standard deviations) and four matched the definition of cerebral
palsy. MRI scans showed severe restrictions of white matter areas, predominant in the frontal lobes in these children.
Conclusions: The neurocognitive outcome of children exposed to perinatal mother-to-child CHIKV infection is poor. Severe
CHIKV neonatal encephalopathy is associated with an even poorer outcome.
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Introduction
Chikungunya virus (CHIKV), a re-emerging alphavirus transmit-
ted by Aedes mosquitoes, has been responsible for major epidemics in
Eastern Africa, numerous islands in the Indian Ocean, India and Sri
Lanka between 2004 and 2007, before spreading for the first time
into the Italian province of Emilia-Romagna [1], where it provoked,
in July 2007, a three-month outbreak of 257 cases [2].
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In Reunion island, a French southern-hemisphere overseas
department of 787,836 inhabitants, the first cases were reported in
March 2005. By October 2006, the disease burden represented a
seroprevalence rate of 38.2% (300,000 infections) [3].
This outbreak drastically changed the paradigm of Chikungu-
nya, previously seen as a non-fatal benign illness, highlighting
atypical and severe forms with case fatalities, as well as long-term
community burden in rheumatology, rehabilitation neurology,
and sensorineural health [4–7].
Among these severe forms, perinatal mother-to-child CHIKV
infections [8–12], gained the attention of caregivers and public
health stakeholders, highlighting the severity of this emerging
infectious disease, henceforth perceived as a global concern with
the potential for lifelong consequences [6].
The spectrum of neonatal CHIKV infection included central
nervous system (CNS) anomalies, hemorrhagic and cardiac
manifestations [8–11]. CHIKV encephalopathy was associated
with brain swelling (early cytotoxic and late vasogenic cerebral
edema) and the presence of viral genoma in the cerebrospinal fluid
(CSF), also found in CHIKV non-encephalopathic form (i.e,
neonatal prostration). These data raised questions about the
primary nature of the neurologic manifestations accompanying
CHIKV infection (neurovirulence or CHIKV-specific neonatal
encephalitis, or non-specific encephalopathy?) [8–9]. Conversely,
neonates born from pregnant women who exhibited signs of
CHIKV infection long before delivery, were apparently healthy at
birth, and intrauterine infection was considered exceptional [9–12].
Prior to this study, the long-term consequences for children exposed
anteor peripartum to this potential neurotropic virus were unknown. The
purpose of this multi-centre ambispective cohort study was to
determine whether the neurocognitive outcome of infected neonates
after two years was different from that of uninfected children.
Methods
Population and setting
The study population consisted of neonates enrolled prospec-
tively in the CHIMERE cohort study [12] and a cohort of
previously infected neonates [8,9]. Neonates were recruited in two
different ways: 1) pregnant women attending the island’s six main
maternity wards between April 15, and November 2006 (78% of
the 14,066 live-births in Reunion island in 2006), were invited to
take part in the study; 2) Further cases of neonatal CHIKV
infection, diagnosed before April 2006, were identified retrospec-
tively from each maternity unit. Delivery room, obstetrical and
neonatal wards are well insulated and air-conditioned, and at the
peak of the CHIKV outbreak, blood-derived products were
imported from a CHIKV-free area, minimizing the risk of
CHIKV transmission by mosquito bite or by blood contamination.
Exposure definition
CHIKV perinatal mother-to-child infection (p-CHIKV infec-
tion) was identified for the infants of mothers infected during
pregnancy with a positive reverse transcriptase polymerase chain
reaction (RT-PCR) result and/or presence of CHIKV-specific
MAC-ELISA IgM antibodies before day 10 (or day 15 in the
CSF). These children were designated as exposed-infected (EI).
Infected neonates were subsequently classified as severe or non-
severe based on convulsions, coma requiring mechanical ventila-
tion, or abnormal magnetic resonance imaging (MRI) scans
indicative of brain swelling (cytotoxic or vasogenic cerebral edema)
during the acute phase of the disease (table S1) [8,9]. Neonates
unable to be breastfed or bottle-fed, previously defined by
pediatricians as ‘‘mild prostrated’’ [9], or neonates requiring
ventilation support for sedation and analgesia were assigned to the
non-encephalopathic group with infants showing no symptoms
compatible with encephalopathy-related neurologic complications.
A major issue was how to define the status of children exposed
to maternal infection and testing negative for CHIKV-specific
IgM antibodies at birth. Thus, ante partum exposure was defined for
the offspring of mothers infected during pregnancy with negative
RT-PCR and IgM at birth, for whom CHIKV-specific IgG
seroreversed during follow-up. These children were designated as
exposed-uninfected (EU). The unexposed-uninfected (UU) group
comprised the children born from seronegative mothers. Other
conditions diagnosed by mandatory maternal screening including
toxoplasmosis, rubella, syphilis, hepatitis B virus, cytomegalovirus
or overt fetal alcohol syndrome were excluded from analysis.
Follow-up
Infants were examined by pediatricians every six months until
the age of two years. MRI scans were proposed for 14 p-CHIKV-
infected children with longitudinal examinations over time. The
brain MRI protocol included axial and sagittal T1-weighted
(T1W) imaging before and after infusion of a gadolinium-based
contrast agent, T1 fast spin echo (FSE), T2-weighted (T2W), T2W
echo-gradient-echo (GRE) et echo-planner imaging (EPI), diffu-
sion-weighted (DW), apparent diffusion coefficients (ADC) map-
ping and spectroscopy imaging sequences.
Outcome measures
Neurocognitive functions of children enrolled in the CHIMERE
cohort were assessed around their second birthday using the
Revised Brunet-Le´zine (RBL) scale [13], after examination by a
pediatrician to rule out acute conditions (e.g., infection, immuni-
zation) likely to interfere with the test. Ophthalmologic and
otorhinolaryngologic check-ups had been performed previously to
determine how the RBL test should be interpreted. The RBL scale
is an early childhood psychomotor development scale covering
four areas of neurodevelopment: movement and posture, coordi-
nation, language, and sociability (table S2). Four subscores can be
calculated for children aged two to 30 months (http://mg.liens.
Author Summary
Chikungunya virus (CHIKV), an alphaviral infection transmit-
ted by day-biting Aedes mosquitoes, is widespread in Asia
and in Africa. Usually, CHIKV causes a self-limiting arthritide,
except in debilitated people and in neonates, for whom it
can lead to severe disease. Mother-to-child perinatal
transmission of CHIKV is a rare event that can occur in the
setting of large-scale outbreaks when the risk of maternal
viremia at the term of pregnancy becomes non-negligible.
In that event, CHIKV can give rise to neonatal infection with
a probability of 50%, and prostration and encephalopathy,
the two leading clinical pictures in the neonate, represent a
continuum in the gradation of an undiscovered central
nervous system involvement. We have followed-up 33
children infected at birth between June 2005 and April 2006
on the island of La Re´union, Indian Ocean, and 135
uninfected controls, for assessing their neurodevelopmental
performance around the age of two years. Fifty-one percent
of infected children had a global neurodevelopmental delay
compared to 15% of uninfected peers. Multivariate analysis
and neuroradiology suggest without irrefutable evidence a
causal relationship between CHIKV infection and neurocog-
nitive outcomes. Our findings suggest that CHIKV infection,
acquired in the perinatal period, can cause severe disease
with lifelong expected disability.
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free.fr/Pediatrie_BLR_pdf), which yield a mean global develop-
mental quotient (DQ) of 100 with a SD of 14 [13]. The
distribution of the each of the separate subscores and the global
DQ are tabulated, enabling specific patterns of developmental
delay to be identified. The RBL scale has been routinely used in
francophone countries, as in the EPIPAGE study [14]. In our
study, the test was performed by two psychometrists blinded to
exposure and took account of the actual age of each child at the
time of evaluation. Children were considered to have normal
development if the DQ was superior to 85. Children with
neurocognitive dysfunction were divided into moderate (DQ 70–
85) and severe (DQ,70) global developmental delay (GND).
Sample size
The sample size was chosen to enable the detection of a ten-
point difference in DQ score between uninfected and infected
children. This could be achieved with 19 EI and 76 uninfected
survivors at the end of the follow-up period. This goal was
impossible to achieve subsequently due to the decline of the
outbreak, so we monitored all previously EI children with
approximately four non-matched controls per infected child,
randomly selected among the offspring of uninfected mothers or
mothers infected during pregnancy without p-CHIKV infection.
Matching on place of birth, gender and gestational age (GA) was
planned but abandoned, given an imbalance of inclusions between
centers and absence of a link between infection and preterm birth
(GA,37 weeks) [8,9,12].
Data analysis
Means and DQ scores were compared using parametric or non-
parametric tests, as appropriate. Proportions of moderate and
severe delays were compared using the Pearson x2 or Fisher tests as
appropriate. Indicators of GND (DQ#85) were investigated using
Poisson regression models with robust variance option to account
for the cohort study design [15], controlling all the putative
confounders, including a social deprivation propensity scale fitted
with the five covariates of primary social determinism linked to
maternal CHIKV infection (i.e., maternal origin, education, marital
status, parity and body mass index) [12]. Incidence rate ratios (IRR)
were given with 95% confidence intervals (95% CI). Sensitivity
analyses using alternative Generalized Linear Model (GLM) log-
binomial, Generalized Estimating Equation (GEE)-logistic, and Cox
proportional hazard multivariate regression models were performed
to strengthen the results. These models have been used extensively
for assessing common dichotomous outcomes (.10%) [16], while
the latter was used more recently in an original way to assess the
recovery of mental function after West Nile virus infection, this
being considered as time-to-event binary outcome [17].
All the interaction terms between the variables included in the
models were tested.
Adjusted attributable risk percents (ARP) for p-CHIKV
infection and other predictors were derived from the GEE-logistic
model to assess the accountability of CHIKV in the pathogenesis
of GND, as follows: ARP (%) = (p12p0/p1)6100, with p1 the
prevalence of GND among infected children and p0 the
prevalence of GND among uninfected peers. Comparisons in
two-by-two adjustments and in GEE-logistic models between
crude and adjusted odd ratios (OR) of p-CHIKV infection and
between the variations of their standard errors (SE) allowed to
distinguish confounding and over-adjustment [18,19]. Confound-
ing was defined using causal diagrams (directed acyclic graphs)
when the adjusted OR for CHIKV infection was altered of more
than 20% of its crude value. Overadjustment was defined when
adjusting on the covariate altered this adjusted OR of 10–20%
with a concomitant change of the SE superior than 20%.
Unnecessary adjustment was considered for intermediate factors,
when adjusting on the covariate did not affect the magnitude of
the point-estimate but decreased its precision (SE change of 10–
20%). Finally, residual confounding (RC) was addressed by
measuring the inverse of the attributable risk fraction (ARF) of
the pool of covariates: RC (%) = 100%2ARF (%).
All analyses were computed in Stata (release 10, StataCorp.
2008, Texas, USA) excluding observations with missing data.
Statistical significance was set at P = 0.05.
Ethics, funding and STROBE statement
Written informed consent was obtained from the parent/
guardian. The study was approved by the ethics committee of
Tours, France (no. 2006-2007) and was reported to the French
Data Protection Authority. The study respected the STROBE
statement (Checklist S1).
Results
Population characteristics
Between April 15 and August 2, 2006, we recruited 1,298
liveborn neonates in the CHIMERE cohort of whom, 653 were
exposed to CHIKV during pregnancy and 591 were tested for
seroreversion. The study population is presented in the figure 1.
Of the 591 children exposed to p-CHIKV infection, we
observed only one case of neonatal infection via intra partum
maternal viremia. At the same time, we enrolled the 36 survivors
infected prior to April 2006. Of the 37 neonates eligible for the
cohort, one family declined participation (a severe encephalopath-
ic case who died around the age of five years in a clinical picture of
cerebral palsy), two were lost to follow-up (previously described as
neonatal prostration), one other could not be assessed due to
severe cerebral palsy. We thus recruited 142 children (71 UU, 71
EU) to serve as non-matched controls for RBL tests, of whom
seven were lost to follow-up.
The characteristics of the 168 children assessed on RBL scales
are described in table 1 and in table S3. Mothers of EI children
were less well educated and were more likely to live alone than
mothers of EU children and far less than UU mothers [12], result
shifted by a repartition bias favoring the participation of better
educated mothers in the control group (differential selection of EU
and UU neonates according to willingness to participate). That is
why, confronted with overt social determinism of CHIKV
infection [20–22], we then used a propensity scale of social risk
of infection to control the role of maternal social characteristics on
DQ while canceling repartition bias (data not shown). It should be
noted that GA was lower in infected children. Shortened gestation
may be due to maternal fever around full-term pregnancy, fever is
known to trigger uterine contractions.
DQ scores and mental delays following exposure
RBL tests were performed on average at 21 months of age
(range 15.8 to 27 months, Kruskal-Wallis test, P = 0.420) and
within close timeframes for the three groups of neonates
(respective ranges: 18.3 to 27 months in UU children, 19.4 to
26.8 months in EU children, 15.8 to 26.7 months in EI children,
Bartlett’s test for equal variances, P = 0.011). Overall, mean DQ
scores and the rate of GND (DQ#85) in UU children were not
different from those observed in EU children and within normal
ranges (table 2). EU and UU children were therefore pooled
together for further analysis of DQ scores and neurocognitive
function. Global DQ scores were lower in infected children than
among uninfected peers (EU or UU).
Neurocognitive Outcome of Neonatal Chikungunya
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Importantly, half the infected children had a GND. However,
when considering specific skills separately, neurodevelopmental
dysfunction was identified in 73.9% (23/33) of infected children,
the areas most affected (DQ#85) being coordination and language
(n = 19), sociability (n = 12), movement/posture (n = 9).
CHIKV infection clinical presentation and neurocognitive
outcomes
Of those who could be assessed by the RBL test, 75.0% of the
children with a history of CHIKV encephalopathy had a GND
(50% moderate, 25% severe) compared with 38.1% of children
Figure 1. Study population. 2 : seronegative for CHIKV-specific IgM and IgG antibodies ; + : seropositive for CHIKV-specific IgG antibodies; M24:
24th month, end of follow-up ; Unexposed - Uninfected and Exposed - Uninfected children were pooled as the Uninfected group (grey lozenge) and
compared with Exposed - infected children as the Infected group (white lozenge) for RBL (Revised Brunet-Le´zine) performance.
doi:10.1371/journal.pntd.0002996.g001
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who presented with a so-called ‘‘mild prostration’’ (table 3).
Among these latter, there was one case of severe GND (DQ,70)
and 33.3% with a moderate GND (DQ 70–85). Of note, non-
severe (prostrated) children exhibited lower performances than
uninfected peers. Thus, the most affected areas in CHIKV non-
encephalopathic children were again coordination and language
(n = 8).
Predictors of mental delay in bivariate analysis
The variables associated with GND are presented in table S4.
Maternal smoking or drinking alcohol, before or during pregnan-
cy, was not associated with neurodevelopmental outcome, only
highly disadvantaged mothers (propensity score .2) were more
likely to have a child with a GND (crude IRR 2.86, 1.04–7.84).
Infected children were more likely to develop GND (crude IRR
3.31, 95%CI 1.97–5.54), irrespective of the clinical presentation
(prostration: crude IRR 2.44, 95%CI 1.24–4.81; encephalopathy:
crude IRR 4.92, 95%CI 2.86–8.42). Other neonatal characteris-
tics linked to DQ score included preterm birth (crude IRR 2.06,
95%CI 1.04–4.08), breastfeeding (crude IRR 0.44, 95%CI 0.25–
0.77), and head circumference at RBL test (z-score,22 S.D,
crude IRR 5.11, 95%CI 3.65–7.13).
Predictors of mental delay in multivariate analysis
Perinatal mother-to-child CHIKV infection was an indepen-
dent predictor of GND (adjusted IRR 2.79, 95%CI 1.45–5.34)
after controlling maternal social situation, head circumference,
small for gestational age (SGA) neonates, this latter factor being
also susceptible to account for head circumference, as encountered
in misdiagnosed fetal alcohol spectrum disorders (table 4). This
finding was confirmed in sensitivity analysis (table S5). Adjusting
for preterm birth, and breastfeeding, both on the causal pathway
from infection to GND or on maternal education level alone, in
addition or in separate models, did not change the association
between CHIKV infection and GND.
Neuroradiologic outcomes
Early MRI scans taken in the two first months of CHIKV
neonatal encephalopathy have been described elsewhere [8,9,23].
Two-week and four-month DWI and T2WI MRI scans are
summarized for a full-term child in figure 2. These two phases
were identified as critical in predicting neurocognitive outcome
because the interval of 15 weeks between is long enough to rule
out the reversible lesions of acute and subacute phases (namely,
hemorrhages, cytotoxic and vasogenic edema) and to observe
chronic lesions of the white matter (WM). Subsequent MRI scan
features of CHIKV neonatal encephalopathy at the early chronic
phase were remarkably consistent (data not shown).
Neuroradiologic features were completed to the age of two years
for eight children (table 5). Though not exhaustive, this
longitudinal study showed improvements in non-severe children,
while persistent injury was observed in five encephalopathic
children, of whom four had microcephaly.
Etiologic fractions of mental delay predictors
Importantly, we did not find that the effect of CHIKV infection
on neurodevelopmental outcome could be confounded by all the
aforementioned covariates (changes ,20% between crude and
adjusted OR, data not shown). Moreover, there was no significant
evidence for over-adjustment (changes .20% between crude and
adjusted SE, data not shown), the most unnecessary adjustment
being on head circumference (table S6a), microcephaly being
definitely on the causal pathway between CHIKV infection and
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GND (figure 2 and table 5). Surprisingly, adjusting for preterm
birth did not contribute to over-adjustment (table S6b). Amongst
the four covariates controlled in the two GEE-Logistic models, p-
CHIKV infection exhibited the strongest etiology fractions (ARP:
65.6% in model A, or 68.2% in model B) for the independent risk
of GND and taken together, these four covariates accounted for
either 95% (model A) or 98% (model B) of the neurocognitive
performance. Otherwise stated, nearly two thirds of the GND
observed in p-CHIKV infected children enrolled in the CHI-
MERE cohort could be attributable to CHIKV and residual
confounding, the proportion of GND not explained by the models,
was estimated at 5% (model A) or at 2% (model B).
Discussion
The CHIMERE cohort study provides the first assessment of
neurocognitive functions of infants infected by maternal-fetal
transmission of CHIKV at birth, on average 21 months after
infection. Overall, infected children exhibit poorer neurocognitive
skills than uninfected peers, as evidenced by lower global DQ
scores and diminished specific neurocognitive skills, even reaching
abnormal ranges for coordination and language. Thus, incidence
of GND in infected children is just over 50% but with a caveat:
CHIKV encephalopathy gives the poorest neurocognitive out-
come and prostration also gives rise to a certain degree of
neurocognitive dysfunction. Furthermore, CHIKV is an indepen-
dent predictor for GND, infected children carrying a three-fold
risk of GND after adjustment for maternal social situation and
neonatal characteristics, such as SGA and head circumference
(table 4). Foremost is the concern that CHIKV-specific neonatal
prostration, which was previously thought to have a favorable
outcome, is more likely to lead to GND than the absence of
infection. Hence neurocognitive dysfunctions were more frequent
in non-severe p-CHIKV-infected children than in uninfected
peers.
Another issue of paramount importance raised by the large-
scale Chikungunya epidemic in La Reunion was that protracted
high fever in the mother might trigger cognitive dysfunction in the
offspring. Thus, 9.8% to 18.2% of pregnant women were
estimated to have been infected [3,9]. Indeed, high fever
throughout pregnancy, associated with other maternal infections,
has been linked to various neurologic outcomes such as neural
tube defects [24], seizures or cerebral palsy [25,26], autism or
epilepsy [27,28], schizophrenia and Parkinson’s disease [29,30].
Maternal hyperthermia and pro-inflammatory cytokines have
been consistently demonstrated in small animal models to affect
apoptosis, perturbation of neuronal migration into the neocortex
and down regulation of brain-specific genes involved in behavioral
changes in the offspring [31,32]. In the CHIMERE cohort, EU
children presented similar DQ scores to UU children, and
maternal exposure to CHIKV during pregnancy had no impact
on child neurocognitive performances at around two years of age.
CHIKV has been thought to infect the CNS since the early
1960’s, based on observations in South East Asia [33], but it is
only since the recent large-scale epidemics in the Indian Ocean
that the prevalence and pathogenesis of neurologic syndromes
have been documented [23]. Neurologic involvement was first
thought to be rare at population level, affecting just one per
thousand infected cases in hospital emergency departments [5].
However, this figure must be reexamined in the light of the
TELECHIK population-based cohort study, which found that ten
percent of CHIKV patients complained of light cerebral disorders,
on average eighteen months after the Reunion island outbreak [6].
Those at risk of severe neurologic damage include preterm and
full-term neonates with an inefficient type-I interferon response
[34], which proved relevant for the neonatal period from an
epidemiologic point of view [9,23]. Major features of severe
neurologic involvement have been described mainly in the neonate
[8,9] and through infancy and childhood [35,36], but neurologic
disorders also unexpectedly emerged in healthy adults with no
known immunosuppression or underlying comorbidities [4,5]. The
CHIMERE cohort provides some novel arguments in favor of
CHIKV neurologic burden, showing areas of neurocognitive
dysfunction for the first time. As expected from early MRI scans
indicative of scattered brain swelling and WM injury [8,9],
neurocognitive dysfunction was extensive and impaired overall
performance was observed in 74% of affected cases. Coordination
and language skills (19/23) were most often affected while
movement/posture (9/23) and sociability (12/23) appeared to be
less affected. These findings are consistent with full neuroradio-
logic follow-up of five cases of CHIKV neonatal encephalopathy
which not only showed the progression of supra-tentorial WM
injury over time, but also N-acetyl-aspartate low peaks, indicating
WM hypometabolism or axonal loss on spectroscopy, particularly
Table 4. Predictors of global neurodevelopmental delay in multivariable analysis, CHIMERE cohort, Reunion Island, 2008.
Poisson regression model Total Children with GND{ Adjusted IRR (95% CI) P value"
Chikungunya virus infection
Yes 32 16 (50.0) 2.79 (1.45–5.34) 0.002
No 119 17 (14.3) 1 - -
Head circumference*
21 S.D#z-score,+2 S.D 143 28 (19.6) 1 - -
22 S.D#z-score,21 S.D 4 1 (25.0) 0.82 (0.27–2.41) 0.718
z-score,22 S.D 4 4 (100) 2.38 (1.41–4.01) 0.001
Developmental quotients (DQ) were measured between 15.8 and 27 months of age.
{Global neurodevelopmental delay (GND) is defined for DQ#85.
Data are numbers, percentages, adjusted IRR (incidence rate ratio) and robust SE (robust standard error).
"P values are given for adjusted Wald tests.
The model is adjusted for the social deprivation propensity score (see table 2 of ref. [14]) assigning positive or negative points to the rounded-value beta coefficients
associated with categories of maternal origin, education, marital status, parity and body mass index; small for gestational age (defined for birth-weight ,10th percentile
of AUDIPOG growth charts);
*head circumference is corrected for 24 months of postnatal age.
doi:10.1371/journal.pntd.0002996.t004
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in the frontal lobes, where coordination and language (Broca area)
centers are located [23,37]. Interestingly, movement/posture,
which implies infra-tentorial networks including basal ganglia,
brainstem and spinal cord structures, was less frequently impaired.
The impact on sociability is difficult to interpret because this
essentially prefrontal cognitive function is not mature enough at
the age of the RBL test to be specifically targeted. However, poor
performance in social skills observed in half the GND infected
Figure 2. MRI scans of a four-month child with CHIKV neonatal encephalopathy. - Child nu4 of Table 5. Full-term small for gestational age
38-week neonate. m5-Apgar score: 10/10. Encephalopathy with sepsis and DIC on day 4. Global developmental delay with DQ = 77 and microcephaly
(head circumference 43 cm, 21.5 z-score SD) at 20 months. Axial sections via the interventricular foramen at day 15 on the left side: Diffusion-
weighted imaging (DWI) with apparent diffusion coefficient (ADC) map (Fig. 2a), and T2-weighted imaging (T2WI) (Fig. 2b). Axial sections via the body
of third ventricular at month 4 on the right side: DWI with ADC map (Fig. 2c), and T2-weighted imaging (Fig. 2d). MRI scans show scattered areas of
cytotoxic edema (violet circles) with decreased-diffusion signals on the ADC map or normal-appearing white matter (green circles) at 15-day scans,
absence of persistent brain swelling (normal ADC) but scattered demyelination with scalloped-appearance of white matter atrophy (green triangles)
including thinning of the corpus callosum (double red lines), passive dilatation of supratentorial interhemispheric subarachnoı¨d spaces (double yellow
arrows). Anatomic abbreviations: WM: white matter; frontal lobes: superior frontal (F1), cingular (CingG), inferior frontal (F3), post-central (PoC), Th:
thalamus, hCN: head of the caudate nucleus; parietal lobes: supra marginalis (SuMa), angular (Ang), superior parietal (P1) gyri; genu (gCC) and
splenium (sCC) of the corpus callosum; occipital lobe (Cuneus); aLV: atrium of the lateral ventricule containing the choroid plexuses.
doi:10.1371/journal.pntd.0002996.g002
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cases raises concerns for the adaptive ability of p-CHIKV-infected
children and deserve further studies.
Another major concern is the development of cerebral palsy
following CHIKV encephalopathy and from the negative associ-
ation between p-CHIKV infection and head growth with infection
impending head growth in nearly two thirds of infected children.
Cases of severe disability, WM and corpus callosum atrophy, and
widening of the ventricular crossroads, in four out five children
with microcephaly following CHIKV encephalopathy reinforces
the argument for causality between p-CHIKV infection, neuronal
loss (due to WM damage), small head circumference (as a result of
reduced brain volume), and cerebral palsy or neurocognitive
dysfunction. These latter findings support the theory of neurotro-
pism of CHIKV, without providing further irrefutable evidence, in
the absence of histopathological data from child autopsy. These
data are consistent with early histopathologic findings observed in
an adult deceased from CHIKV encephalomyeloradiculitis whose
brain was swollen and showed microglial activation and
demyelination foci located in the subcortical WM [38]. This is
also in line with WM injuries found in neonatal encephalitis, such
as those resulting from enterovirus or parechovirus infections
[39,40]. Whether it is caused by microglia following an innate
immune response possibly leading to neuronal apoptosis and
axonal injury [41,42] remains to be confirmed for CHIKV
encephalopathy in humans [43]. Nevertheless, there are several
arguments that this pathogenesis is shared with other viral
encephalitides or periventricular leucomalacy in preterm neo-
nates. Certainly, both conditions target the periventricular
germinal areas of neuron production and repair, involve
ischemic-reperfusion and inflammation mechanisms, patterns
found in CHIKV encephalopathy [9,36]. If true, the most
plausible pathway for the CHIKV to disrupt the CNS would thus
be to target first and foremost the richly vascularized choroı¨d
plexuses, then the leptominges and the ependymal wall [34,44],
using monocytes to disseminate via the bloodstream [45]. This is
supported by reduction of T1 elongation times (WM hyper-
intensities on T1WI scans) on MRI of a few infants (data not
shown), consistent with a certain degree of microglial activation
leading to demyelination [43,46], in the vicinity of the choroı¨d
plexuses (of which the epithelial layer lining the lateral ventricles).
We hypothesize that CHIKV in targeting stromal ependymal
cells could hijack stem cell production and neuron migration to
damaged areas of the brain [47], and could impair myelin sheath
production by down-regulating the biosynthesis or cerebral
uptake of cholesterol [48–50], a set of conditions that would
reduce WM, brain volume and lead to neurocognitive dysfunc-
tion. Indeed, demyelination, the putative hallmark of CHIKV
neonatal encephalopathy might also be caused by autoreactive
CD8(+)T lymphocytes to clear virally infected target cells, as
observed with oligodendrocytes in several mouse models of
encephalitis [51,52], CD8(+) T cells being the most common
phenotype of peripheral blood mononuclear cells found in the
CSF of cynomolgus macaques, in the only nonhuman primates
model challenged by CHIKV [53]. Whatever the mechanism
involved in the CNS, CHIKV pathogenesis has still many gray
areas, such as the precise role of brain outer cells [34,44],
microglia [42,43,48], the possibility of parenchymal cells inva-
siveness [33,42], or primary metabolic encephalopathy [54].
Our study has some strengths and limitations. Exposure was
able to identify with certainty, encephalopathy from other causes
and embryofœtopathies were ruled out, unexposed children being
randomly selected through the maternal CHIMERE cohort and
the serological status of each infant was known [12]. The sera of
exposed children were monitored until seroreversion to rule out
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misclassification of children infected early in pregnancy [55].
There was no residual participation bias driven by maternal
situation while using a propensity scale of social disadvantage. In
order to limit information bias, psychometrists were unaware of
the infectious status of the children. In the absence of matching
strategy, assessment of neurocognitive function took account
actual age and was set-up within close timeframes to avoid
temporal bias between infected and uninfected cohorts. Most of
prevalent cases of neonatal infection had been diagnosed
prospectively in real-time with the help of the same lab facilities
[9], so that there is no recall bias affecting their classification as EI.
It should be noted that the neuroradiologic monitoring was
uncontrolled, incomplete, and oriented potentially towards the
most severely infected children. However, the redundancy of our
observations makes unlikely the spectrum of the neuropathologic
findings would have not been captured. Finally, we found no
imbalance in our different models between over-adjustment and
residual confounding that could skew significantly the ‘‘total causal
effect’’ of p-CHIKV infection on neurocognitive outcome.
However, multivariate analysis in our study did not aim to
estimate the ‘‘true force’’ of the infection in predicting child
psychomotor impairment, but merely, to argue for causality while
controlling for various accurate predictors of psychomotor
development. In consequence, we can reasonably propose that
CHIKV infection is the leading contributor for neurocognitive
impairment in p-CHIKV-infected children and that the social
disadvantage of mothers, growth retardation, or head circumfer-
ence, i.e., a proxy of cerebral volume, or other factors (e.g., preterm
birth or breastfeeding) in relation to these variables, accounted for
a lesser part of this association. This being said, we advocate a
caveat in the interpretation of causality: as with several arboviruses
causing mild illness, but rarely encephalopathy, our data preserve
a considerable room for uncertainty regarding the potential for
neurovirulence of CHIKV, so that it is impossible to claim that
CHIKV is responsible of poor neurodevelopmental outcome.
Indeed, the possibility of neuroinvasiveness of CHIKV remains to
be shown in humans.
Several lessons can be drawn from the CHIMERE cohort
study. First, as for other neglected tropical diseases [20], CHIKV
infection tends to impact impoverished mothers [12] and more
often their children (table 1). However, mothers infected by
CHIKV during pregnancy may be reassured: the prognosis of
their uninfected child is identical to that of children exposed in utero
to maternal fever, for which there is currently no convincing
evidence of subsequent neurocognitive impairment. By contrast,
the neurocognitive outcome of infected children is poor and must
be monitored throughout childhood to anticipate the psychomo-
tor, cognitive and behavioral therapies designed to limit the extent
of neurocognitive dysfunction and the lifelong consequences of
‘‘CHIKV driven disability’’. Thus, in the absence of effective
postponing of delivery or caesarian section [9], these issues should
prompt further research aimed at preventing or limiting infection,
such as vaccination or immunotherapy. Our findings will guide
clinicians, public health specialists, policy makers and other
stakeholders dealing with the challenges of maternal-fetal trans-
mission of CHIKV during large-scale outbreaks.
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